Джерело: Yoshida T. Safery Guidelines for PDT in The Field of OtorhinolaryngoloГр and Head and Neck Disorders, 2012
1. Akimoto, T., Nonaka, T., Kitamoto, Y., Ishikawa, H., Ninomiya, H., Chikamatsu, K., Furuya, N., Hayakawa, K., Mitsuhashi, N. & Nakano, T. (2006) Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. //3Int. J. Radiat. Oncol. Biol.Phys., 64, 995-1001.
2. Chrischilles, E.A., Pendergast, J.F., Kahn, K.L., Wallace, R.B., Moga, D.C., Harrington, D.P., Kiefe, C.I., Weeks, J.C, West, D.W., Yousuf Zafar, S. & Fletcher, R.H. (2010) Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. //J. Clin. Oncol., 28, 620-627.
3. Fujii, M., Tomita, K., Nishijima, W., Tsukuda, M., Hasegawa, Y., Ishitoya, J., Yamane, H., Homma, A. & Tomita, T. (2010) Phase I/II study of S-1 plus Cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer. //Jpn. J. Clin. Oncol., 40, 214-221.
4. Fushimi, K., 4.Hashimoto, H., Imanaka, Y., Kuwabara, K., Horiguchi, H., Ishikawa, K.B. & Matsuda, S. (2007) Functional mapping of hospitals by diagnosis-dominant case-mix analysis.// BMC Health Serv. Res., 7, 50.
5. Japan Society of Head and Neck Cancers. (2009) //Clinical guideline for Head and Neck Cancers 2009 [in Japan].
6. Japanese Society of Therapeutic RadioloГр and Oncology. (2008) //Guideline for Radiotherapy Planning 2008 [in Japan].
7. Lalami, Y., Castro, Jr. G., Bernard-Marty, C. & Awada, A. (2009) Management of head and neck cancer in elderly patients. //Drugs Aging, 26, 571-583.
8. Lichtman, S.M., Wildiers, H., Chatelut, E., Steer, C., Budman, D., Morrison, V.A., Tranchand, B., Shapira, I. & Aapro, M. (2007) //International society of geriatric Oncology chemotherapy taskforce.
9. Matsuda, S., Ishikawa, B.K., Kuwabara, K., Fujimori, K., Fushimi, K. & Hashimoto, H. (2008) Development and use of the Japanese case-mix system. //Eurohealth, 14, 25-30.
10. Matsuda, S., Ishikawa, B.K., Kuwabara, K., Fujimori, K., Fushimi, K. & Hashimoto, H. (2009) DPC based health service planning for cancer medicine. //Asian Pac. J. Dis. Manag., 3, 11-19.
11. Nakamura, K., Tahara, M., Kiyota, N., Hayashi, R., Akimoto, T., Fukuda, H., Fujii, M. & Boku, N. (2009) Phase II trial of concurrent сhemoradiotherapy with S-1 plus Cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).// Jpn. J. Clin. Oncol., 39, 460-463.
12. Pfister, D.G., Laurie, S.A., Weinsteain, G.S., Mendenhall, W.M., 66 Y. Ichimiya et al. 13.Adelstein, D.J., Ang, K.K., Clayman, G.L., Fisher, S.G., Forastiere, A.A., Harrison, L.B., Lefebvre, J.L., Leupold, N., List, M.A., O'Malley, B.O., Patel, S., Posner, M.R., Schwartz, M.A. & Wolf, G.T. (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx preservation strategies in the treatment of laryngeal cancer.// J. Clin. Oncol., 24, 3693-3704.
13. Pignon, J.P., Bourhis, J., Domenge, C. & Designe, L. (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group- Meta-Analysis of Chemotherapy on Head and Neck Cancer.// Lancet, 355, 949-955.
14. Posner, M.R., Hershock, D.M., Blajman, C.R., Mickiewicz, E.,Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D.M., Cullen, K., Ervin, T.J., Murphy, B.A., Raez, L.E., Cohen, R.B., Spaulding, M., Tisher, R.B., Roth, B., Viroglio, R.C., Venkatesan, V., Romanov, I., Agarwala, S., Harter, K.W., Dugan, M., Cmelak, A., Markoe, A.M., Read, P.W., Steinbrenner, L., Coleva, A.D., Norris, C.M. & Haddad, R.I. (2007) Cisplatin and Fluorouracil alone or with Docetaxel in head and neck cancer. //N. Engl. J. Med., 357, 1705-1715.
15. Salama, J.K., Seiwert, T.Y. & Vokes, E.E. (2007) Chemoradiotherapy for locally advanced head and neck cancer. //J. Clin. Oncol., 25, 4118-4126.
16. Teshima, T., Numasaki, H., Shibuya, H., Nishio, M., Ikeda, H., Ito, H., Sekiguchi, K., Kamikonya, N., Koizumi, M., Tago, M., Nagata, Y., Masaki, H., Nishimura, T. & Yamada, S. (2008) Japanese structure survey of radiation Oncology in 2005 based on institutional stratification of patterns of care study. //Int. J. Radiat. Oncol. Biol. Phys., 72, 144-152.
17. Vermorken, J.B., Remenar, E., Herpen, C., Gorlia, T., Mesia, R., Degardin, M., Stewart, J.S., Jelic, S., Betka, J., Preiss, J.H.,Weyngaert, D., Awada, A., Cupissol, D., Kienzer, H.R., Rey,A., Desaunois, I., Bernier, J. & Lefebvre, J.L. (2007) Cisplatin,Fluorouracil, and Docetaxel in unresectable head and neck cancer.// N. Engl. J. Med., 357, 1695-1704.
18. Hoffman H.T. Porter K. Karnel I.H. ,et al. (2006)Laryngeal cancer in the United States changers in dermografics patterns of care, and survival //Laryngoscope,116: 1-13:
19. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. PatholoГр and Genetics of Head and Neck Tumours.Lyon: IARC Press 2005.
20. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. //N Engl J Med 2004; 350: 1945–1952.
21. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for locoregionally advanced squamous cell head and neck cancer: 5-year survivaldata from a phase III randomised trial, and relation between cetuximab-induced rash and survival. //Lancet Oncol 2010; 11: 21–28.
22. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. //N Engl J Med 2004; 350: 1937–1944.
23. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 //Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0. Lyon: IARC Press 2004.
24. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.// N Engl J Med 2003; 349: 2091–2098.
25. Forastiere AA, Metch B, Schuller DE et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group Study. //J Clin Oncol 1992; 10: 1245–1251.
26. Hitt R, Lopez-Pousa A, Martinez-Trufero J et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. //J Clin Oncol 2005; 23: 8636–8645.
27. Pignon Aure´ lie le Maıˆtre JP, Maillard E et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 andomised trials and 17,346 patients.// Radiother Oncol 2009; 92: 4–14.
28. Posner MR, Hershock DM, Blajman CR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. //N Engl J Med 2007; 357: 1705–1715.
29. Sant M, Allemani C, Santaquilani M et al. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. //Eur J Cancer 2009; 45: 931–991.
30. Vermorken JB, Remener E, van Herpen C et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. //N Engl J Med 2007; 357: 1695–1704.
31. Vermorken JB, Mesia R, Rivera F et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. //N Engl J Med 2008; 359: 1116
32. Carvalho, A. L., Pintos, J., Schlecht, N. F., Oliveira, B. V., Fava, A. S., Curado, M. P., Kowalski, L. P. & Franco, E. L. (2002) Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck. //Archives of OtolaryngoloГр - Head and Neck Surgery, 128: 313-318.
33. Chan, T. V. (2010) The patient with sore throat. [Review] [44 refs].// Medical Clinics of North America, 94: 923-943. Narrative review
34. Chen, A. Y., Frankowski, R., Bishop-Leone, J., Hebert, T., Leyk, S., Lewin, J. & Goepfert, H. (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer - The M. D. Anderson dysphagia inventory. //Archives of OtolaryngoloГр-Head & Neck Surgery, 127: 870-876.
35. Chen, J.-J. (2007) Laryngeal lesions in patients with chronic cough and normal chest radiographs and auscultation. //Tzu Chi Medical Journal, 19: 145-151+182.
36. Chodynicki, S. & Pyd, M. (1985) [Use of questionnaires in the early diagnosis of precancerous conditions and cancer of the larynx]. [Polish].// Polski Tygodnik Lekarski, 40: 1089-1091.
37. Christopoulos, T. A., Papageorgakopoulou, N., Theocharis, D. A., Aletras, A. J., Tsiganos, C. P., Papadas, T. A., Mastronikolis, N. S., Goumas, P. & Vynios, D. H. (2004) Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma. //International Journal of Oncology, 25: 481-485.
38. Cnossen, I. C., de, B. R., Rinkel, R. N., Eerenstein, S. E., Rietveld, D. H., Doornaert, P., Buter, J., Langendijk, J. A., Leemans, C. R. & Verdonck-de Leeuw, I. M. (2012) Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice. //Supportive Care in Cancer, 20: 2925-2931.
39. Cohen, S. M., Kim, J., Roy, N., Asche, C. & Courey, M. (2012) Prevalence and causes of dysphonia in a large treatment-seeking population.// Laryngoscope, 122: 343-348.
40. Cohen, S. M., Kim, J., Roy, N. & Courey, M. (2014) Factors influencing referral of patients with voice disorders from primary care to otolaryngoloГр. //Laryngoscope, 124: 214-220.
41. Cohen, S. M., Dinan, M. A., Roy, N., Kim, J. & Courey, M. (2014) Diagnosis Change in Voice-Disordered Patients Evaluated by Primary Care and/or OtolaryngoloГр: A Longitudinal Study.
42. Cotulbea, S., Marin, I., Golumba, R., Barbos, R., Valean, M. & Anghel, I. (1986) [Early diagnosis of laryngeal cancer in patients in the area of the Timisoara ENT Clinic]. [Romanian]. //Revista de Chirurgie Oncologie Radiologie ORL Oftalmologie Stomatologie - Oto-Rino-Laringologia, 31: 137-141.
43. Dammer, R., Bonkowski, V., Kutz, R., Friesenecker, J. & Schusselbauer, T. (1999) [Early detection of multiple tumors in primary diagnosis of oral carcinomas using panendoscopy]. [German]. //Mund-, Kiefer- und Gesichtschirurgie, 3: 61-66.
44. De, V. A. & Vicini, C. (2013) Narrow-band imaging in the early detection of laryngeal cancer: A prospective study.// European Archives of Oto-Rhino-LaryngoloГр, 270: 389.
45. Dean, S. S. (2134) OtolaryngoloГр head and neck surgery. A review of malignancies. Australian Family Physician, 23: 2130-2131. Narrative review
46. Dechaphunkul, T. (2011) EpidemioloГр, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital.// Journal of the Medical Association of Thailand, 94: 355-360.
47. Reiter, R. & Brosch, S. (2009) [Chronic laryngitis--associated factors and voice assessment]. [German]. //Laryngo- Rhino- Otologie, 88: 181-185.
48 .Resouly, A., Hope, A. & Thomas, S. (2001) A rapid access husky voice clinic: useful in diagnosing laryngeal patholoГр. //Journal of LaryngoloГр & OtoloГр, 115: 978-980.
49. Reulbach, T. R., Belafsky, P. C., Blalock, P. D., Koufman, J. A. & Postma, G. N. (2001) Occult laryngeal patholoГр in a community-based cohort. //OtolaryngoloГр - Head & Neck Surgery, 124: 448-450.
50. Righini, C. A., Karkas, A., Morel, N., Soriano, E. & Reyt, E. (2008) [Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx]. [Review] [76 refs] [French].// Presse Medicale, 37: 1229-1240.
51. Sereg-Bahar, M., Jerin, A. & Hocevar-Boltezar, I. (2013) The role of gastroesophageal reflux in pathogenesis of benign and malignant laryngeal lesions. //European Archives of Oto-Rhino-LaryngoloГр, 270: 398.
52. Sharma, S. J., Linke, J. J., Kroll, T., Klussmann, J.-P., Guntinas-Lichius, O. & Wittekindt, C. (2013) Current practice of tumour endoscopy in German ENT-clinics. [German]. //Laryngo- Rhino- Otologie, 92: 166-169.
53. Singh, H. & Chauhan, A. (2011) Primary small cell carcinoma of the larynx: report of a rare tumor. //Case Reports in Oncological Medicine, 2011: 978676.
54. Siupsinskiene, N., Vaitkus, S., Grebliauskaite, M., Engelmanaite, L. & Sumskiene, J. (2008) Quality of life and voice in patients treated for early laryngeal cancer. //Medicina (Kaunas, Lithuania), 44: 288-295.
55. Smith, M. D., Fleming, J., Lew-Gor, S., Simcock, R., Weighill, J. & Harries, M. L. (2012) 4-Year demographic study of laryngeal carcinoma. //OtolaryngoloГр - Head and Neck Surgery (United States), 147: 144.
56. Smulders, Y., De Bondt, B. J., Lacko, M., Hodge, J. & Kross, K. (2009) Laryngeal tuberculosis presenting as a supraglottic carcinoma: a case report and review of the literature.// Journal of Medical Case Reports, 3: 9288.
57. Splete, H. (2009) Primary care physicians can expose laryngeal Ca.// Oncology Report, 31. Letter
58. Steiner, W., Jaumann, M. P. & Pesch, H. J. (1980) [Early detection of laryngeal cancer (author's transl)]. [German]. //Therapeutische Umschau, 37: 1087-1091. Narrative review
59. Steiner, W. (1982) Aspects of clinical differential diagnosis and therapy of early laryngeal cancer (microcarcinoma). Clinics in Oncology, 1: 489-493.
60. Steiner, W. (1982) Early detection of cancer in the upper aerodigestive tract and its prophylaxis. [German]. //Munchener Medizinische Wochenschrift, 124: 22-30. Narrative review
61. Stephen, J. K., Chen, K. M., Shah, V., Havard, S., Lu, M., Schweitzer, V. P., Gardner, G. & 62.Worsham, M. J. (2012) Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. //OtolaryngoloГр - Head & Neck Surgery, 146: 730-738.
62. Stiefelhagen, P. van, A. M., Heule-Dieleman, H. A., de Boer, M. F., Kaanders, (2010) [Clinical assessment of a "voice disorder" with simple and follow-up of laryngeal carcinomas. //Radiotherapy & Oncology, 74: 337-344.
63.Kremer, B., Leemans, C. R., Marres, H. A., Manni, J. J., Langendijk, J. A., Levendag, P. C., Tjho-Heslinga, R. E., de Jong, J. M., Uyl-de Groot, C. A. & Knegt, P. P. (2005) Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. //Radiotherapy & Oncology, 74: 337-344.
64.Heule-Dieleman, H. A., de Boer, M. F., Kaanders, J. H., Baatenburg de Jong, R. J., 64.Kremer, B., Leemans, C. R., Marres, H. A., Manni, J. J., Langendijk, J. A., Levendag, P. C., Tjho-Heslinga, R. E., de Jong, J. M., Uyl-de Groot, C. A. & Knegt, P. P. (2005) Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. //Radiotherapy & Oncology, 74: 337-344.
65. Vecerina, V. S., Kovac, D., Seiwerth, S. & Manojlovic, S. (1997) Correlation between instability of fundamental voice frequency and malignant infiltration of vocal fold nerve endings.// Acta Oto-Laryngologica Supplement, 527: 131-133.
66. Vlachtsis, K., Naoum, V., Karasmanis, I. & Nikolaou, A. (2011) Inflammatory myofibroblastic tumor of the larynx. //European Archives of Oto-Rhino-LaryngoloГр, 268: 799.
67. Vracko-Tusevljak, M. & Kambic, V. (1989) [The significance of psychological factors in the early diagnosis of laryngeal and hypopharyngeal tumors]. [German]. //Laryngo- Rhino- Otologie, 68: 118-121.
68. Wenig, B. M., Hyams, V. J. & Heffner, D. K. (1988) Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. [Review] [103 refs].// Cancer, 62: 2658-2676.
69. Wilkins, T., Gillies, R. A., Getz, A., Zimmerman, D. & Kang, L. (2010) Nasolaryngoscopy in a family medicine clinic: indications, findings, and economics.// Journal of the American Board of Family Medicine: JABFM, 23: 591-597.
70. Wunsch, F., V (2004) The epidemioloГр of laryngeal cancer in Brazil. [Review] [89 refs]. //Sao Paulo Medical Journal Revista Paulista de Medicina, 122: 188-194. Narrative review
71. Yoshino, K., Endo, M., Ishikawa, N. & Takahashi, Y. (1995) Diagnosis and treatment of metachronous cancers in the esophagus and the head and neck region. //Journal of Surgical Oncology, 58: 246-251.
72.van, A. M., Heule-Dieleman, H. A., de Boer, M. F., Kaanders, J. H., Baatenburg de Jong, R. J., Kremer, B., Leemans, C. R., Marres, H. A., Manni, J. J., Langendijk, J. A., Levendag, P. C., Tjho-Heslinga, R. E., de Jong, J. M., Uyl-de Groot, C. A. & Knegt, P. P. (2005) Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. //Radiotherapy & Oncology, 74: 337-344.
73. Vecerina, V. S., Kovac, D., Seiwerth, S. & Manojlovic, S. (1997) Correlation between instability of fundamental voice frequency and malignant infiltration of vocal fold nerve endings.// Acta Oto-Laryngologica Supplement, 527: 131-133.
74. Vlachtsis, K., Naoum, V., Karasmanis, I. & Nikolaou, A. (2011) Inflammatory myofibroblastic tumor of the larynx. //European Archives of Oto-Rhino-LaryngoloГр, 268: 799.
75.Vracko-Tusevljak, M. & Kambic, V. (1989) [The significance of psychological factors in the early diagnosis of laryngeal and hypopharyngeal tumors]. [German]. //Laryngo- Rhino- Otologie, 68: 118-121.
76.Wenig, B. M., Hyams, V. J. & Heffner, D. K. (1988) Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. [Review] [103 refs]. //Cancer, 62: 2658-2676.
77.Wilkins, T., Gillies, R. A., Getz, A., Zimmerman, D. & Kang, L. (2010) Nasolaryngoscopy in a family medicine clinic: indications, findings, and economics.// Journal of the American Board of Family Medicine: JABFM, 23: 591-597.
78.Wunsch, F., V (2004) The epidemioloГр of laryngeal cancer in Brazil. [Review] [89 refs].// Sao Paulo Medical Journal Revista Paulista de Medicina, 122: 188-194. Narrative review
79. Ya, S. (1985) Diagnosis of laryngeal cancer in tuberculous patients. [Russian]. //Problemy Tuberkuleza, 63: 10-13.
80.Yoshino, K., Endo, M., Ishikawa, N. & Takahashi, Y. (1995) Diagnosis and treatment of metachronous cancers in the esophagus and the head and neck region. //Journal of Surgical Oncology, 58: 246-251.
81.Y., Arens, C. & Glanz, H. (2005) [Autofluorescence endoscopy for diagnosing early laryngeal cancer and its precursor lesions]. [Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi// Chinese Journal of OtorhinolaryngoloГр Head & Neck Surgery, 40: 696-700.
82.Lim,S. (2014). Are we performing more laryngeal biopsies, and if so, why? A decade of results. //Journal of LaryngoloГр and OtoloГр, 28, 3.
83.Lowe, V. J., Kim, H., Boyd, J. H., Eisenbeis, J. F., Dunphy, F. R. & Fletcher, J. W. (1999) //Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. RadioloГр, 212: 799-802.
84.Lydiatt, D. D. (2002) Medical malpractice and cancer of the larynx. //Laryngoscope, 112: 445-448.
85. Mancuso, A. A., Tamakawa, Y. & Hanafee, W. N. (1980) CT of the fixed vocal cord. //AJR.American Journal of RoentgenoloГр, 135: 7529-7534.
86.Mashkova, T. A., Ovsiannikov, I. & Panchenko, I. G. (2010) [Potential of fibrolaryngoscopy for the improvement of diagnosis of laryngeal diseases]. [Russian].//Vestnik Otorinolaringologii.(5):28-9, 2010., 28-29.
87.Mehlmann, M., Betz, C. S., Stepp, H., Arbogast, S., Baumgartner, R., Grevers, G. & Leunig, A. (1999) Fluorescence staining of laryngeal neoplasms after topical application of 5-aminolevulinic acid: preliminary results. //Lasers in Surgery & Medicine, 25: 414-420.
88.Rousset, J., Abgral, R., Chinellato, S., Garetier, M., Barberot, C., Valette, G., Potard, G., Le, B. T. & Salaun, P. Y. (2013)// Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.// Head & Neck, 35: E202-E204.
89.Sahin, M., Kirazli, T., Ozturk, K. & Ogut, M. F. (2013) [A presentation of a practical algorithm which can be used in the management of vocal cord nodules, polyps and intraepithelial neoplasias]. [Turkish]. Kulak Burun Bogaz Ihtisas Dergisi//Journal of Ear, Nose & Throat: Kbb, 23: 96-103.
90.Sereg-Bahar, M., Jerin, A. & Hocevar-Boltezar, I. (2013) The role of gastroesophageal reflux in pathogenesis of benign and malignant laryngeal lesions. //European Archives of Oto-Rhino-Suspected
91.Sharma, S. J., Linke, J. J., Kroll, T., Klussmann, J.-P., Guntinas-Lichius, O. & Wittekindt, C. (2013) Current practice of tumour endoscopy in German ENT-clinics. [German]. //Laryngo- Rhino- Otologie, 92: 166-169.
92.Naidu, H., Noordzij, J. P., Samim, A., Jalisi, S. & Grillone, G. A. (2012) Comparison of efficacy, safety, and cost-effectiveness of in-office cup forcep biopsies versus operating room biopsies for laryngopharyngeal tumors.// Journal of Voice, 26: 604-606.
93.Ni, X. G., He, S., Xu, Z. G., Lu, N., Gao, L., Yuan, Z., Zhang, Y. M., Lai, S. Q., Yi, J. L., Wang, X. L., Zhang, L., Li, X. Y. & Wang, G. Q. (2010) [Application of narrow band imaging endoscopy in the diagnosis of laryngeal cancer]. [Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi// Chinese Journal of OtorhinolaryngoloГр Head & Neck Surgery, 45: 143-147.
94.Ni, X. G., He, S., Xu, Z. G., Gao, L., Lu, N., Yuan, Z., Lai, S. Q., Zhang, Y. M., Yi, J. L., Wang, X. L., Zhang, L., Li, X. Y. & Wang, G. Q. (2011) Endoscopic diagnosis of laryngeal cancer and precancerous lesions by narrow band imaging. //Journal of LaryngoloГр & OtoloГр, 125: 288-296.
95. Nix, P. A. & Salvage, D. (2004) Neoplastic invasion of laryngeal cartilage: the significance of cartilage sclerosis on computed tomography images. //Clinical OtolaryngoloГр & Allied Sciences, 29: 372-375.
96.Paczona, R., Temam, S., Janot, F., Marandas, P. & Luboinski, B. (2003) Autofluorescence videoendoscopy for photodiagnosis of head and neck squamous cell carcinoma.// European Archives of Oto-Rhino-LaryngoloГр, 260: 544-548.
97.Pan, C. T., Lee, L. A., Fang, T. J., Li, H. Y., Liao, C. T. & Chen, I. H. (2013) NBI flexible laryngoscopy targeted tissue sampling in head and neck cancer patients with difficult airways.// European Archives of Oto-Rhino-LaryngoloГр, 270: 263-269.
98. Rafferty, A., Greensmith, M., Robinson, S. & Jose, J. (2012) Laryngeal cancer social marketing project.// Clinical OtolaryngoloГр, 37: 46.
99.Ramirez-Anguiano, J., Lara-Sanchez, H., Martinez-Banos, D. & Martinez-Benitez, B. (2012) Extramedullary plasmacytoma of the larynx: a case report of subglottic localization.// Case Reports in OtolaryngoloГр Print, 2012: 437264.
100. Reiter, R. & Brosch, S. (2009) [Chronic laryngitis--associated factors and voice assessment]. [German]. //Laryngo- Rhino- Otologie, 88: 181-185.
101. Smith, M. D., Fleming, J., Lew-Gor, S., Simcock, R., Weighill, J. & Harries, M. L. (2012) 4-Year demographic study of laryngeal carcinoma.// OtolaryngoloГр - Head and Neck Surgery (United States), 147: 144.
102.Stoeckli, S. J. & Broglie, M. A. (2012) Sentinel node biopsy for early oral carcinoma. //Current Opinion in OtolaryngoloГр & Head and Neck Surgery, 20: 103-108.
103. Stone, N., Stavroulaki, P., Kendall, C., Birchall, M. & Barr, H. (2000) Raman spectroscopy for early detection of laryngeal malignancy: preliminary results. //Laryngoscope, 110: t-63.
104. Szmeja, Z., Wierzbicka, M. & Kordylewska, M. (1999) The value of ultrasound examination in preoperative neck assessment and in early diagnosis of nodal recurrences in the follow-up of patients operated for laryngeal cancer. //European Archives of Oto-Rhino-LaryngoloГр, 256: 415-417.
105.Ustundag, E., Kaur, A. C., Boyaci, Z., Keskin, G. & Aydin, O. (2006) Combined use of histopatholoГр with touch smear cytoloГр in biopsies of the larynx. //European Archives of Oto-Rhino-LaryngoloГр, 263: 866-871.
106, van Agthoven, M., Heule-Dieleman, H. A. G., de Boer, M. F., Kaanders, J. H. A. M., de Jong, R. J. B., Kremer, B., Leemans, C. R., Marres, H. A. M., Manni, J. J., Langendijk, J. A., Levendag, P. C., Tjho-Heslinga, R. E., de Jong, J. M. A., Uyl-de Groot, C. A. & Knegt, P. P. (2005)// Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. Radiotherapy and Oncology, 74: 337-344.
107. Warnecke, A., Averbeck, T., Leinung, M., Soudah, B., Wenzel, G. I., Kreipe, H. H., Lenarz, T. & Stover, T. (2010)// Contact endoscopy for the evaluation of the pharyngeal and laryngeal mucosa. Laryngoscope, 120: 253-258.
108.Zan, E., Yousem, D. M. & Aygun, N. (2011)// Asymmetric mineralization of the arytenoid cartilages in patients without laryngeal cancer. Ajnr: American Journal of NeuroradioloГр, 32: 1113-1118.
109. Zargi, M., Smid, L., Fajdiga, I., Bubnic, B., Lenarcic, J. & Oblak, P. (1997) //Detection and localization of early laryngeal cancer with laser-induced fluorescence: preliminary report. European Archives of Oto-Rhino-LaryngoloГр, 254: Suppl-6.
110. Zargi, M., Fajdiga, I. & Smid, L. (2000)//Autofluorescence imaging in the diagnosis of laryngeal cancer. European Archives of Oto-Rhino-LaryngoloГр, 257: 17-23.
111. Захарцева, . Л.М. , Е.А.Пикур (2013)// Частота експресии белка р 16 INK4a и наличие вирусов паппиломы человека при дисплазии шейки матки. Онкология.т.15. №1, с.9-11
112. Брауншвейг Т.Левандовски А., Смеетс Д., Болотин М.В. (2013) //Плоскоклеточный рак головы и шеи:новые перспективы лечения? Опухоли головы и шеи №3:6-11
113. Specenier P, and Vermorken J.B. //Cetuximab: its unique place in head and neck cancer treatment . Biologics 2013: 7:77-90
114. Neuman S. Eribulin , a simplified ketone analog of the tubulin inhibitor halichondrin B , for potential treatment of cancer. //Curr Opin Investig Drugs 2007; (12): 1057-667
115. Syrjanen K., Syrjanen S. and Pyrhonen S. Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas.// ORL J Otorhinolaryngol Relat Spec 1982;44(6):323–34.
116 . C. Badouala C., C. Righinib C., Barryc B., Bertolusd C., Nadéria S., Morinièree S., de Raucourtf D. Pre-therapeutic histological and cytological assessment in head and neck squamous cell carcinomas.// European Annals of OtorhinolaryngoloГр, Head and Neck diseases (2012) 129, 319—326
117. Petrelli NJ, Winer EP, Brahmer J et al. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.// J Clin Oncol 2009: 27(35): 6052-6069
118. Sibata C.H. [et al.] Photodynamic therapy in Oncology // J. Expert. Opin. Pharmacother. – 2001. – Vol. 2., №.6: 917-927
Інформація, опублікована на даному сайті, орієнтована на загальне ознайомлення та жодним чином не може бути використана в якості медичних, практичних або комерційних рекомендацій. У зв’язку з цим, Сайт «Школи доказової медицини» не несе жодної відповідальності за негативні наслідки, отримані через використання матеріалів, викладених на даному сайті. Документація з фармацевтичних продуктів не є рекламою та не призначена для того, щоб використовувати її замість консультації з кваліфікованими фахівцями в галузі медицини та інших галузях. Документація з фармацевтичних продуктів надається за вашою згодою відповідно до вимог ч.ч. 1, 2 ст. 15 Закону України «Про захист прав споживачів» від 12.05.1991 р. № 1023-XII. Якщо вам потрібна консультація з конкретного питання, пов’язаного зі здоров’ям, необхідно звернутися до фахівців- професіоналів.
Продовжуючи своє перебування на сайті, ви підтверджуєте свою згоду на дистанційне отримання інформації про лікарські та косметичні засоби (включаючи інформацію про рецептурні лікарські засоби) на підставі вимог ч.ч. 1, 2 ст. 15 Закону України «Про захист прав споживачів» від 12.05.1991 р. № 1023-XII.
Уся інформація, яка міститься на даному сайті, подана з освітньою метою виключно для медичних та фармацевтичних працівників і не замінює консультації лікаря.